Context Therapeutics Inc. (CNTX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $66.00M | -30.1% |
| 2024 | $94.43M | +553.5% |
| 2023 | $14.45M | -59.3% |
| 2022 | $35.50M | -28.5% |
| 2021 | $49.64M | +16976.1% |
| 2020 | $290.7K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $66.00M | -30.1% |
| 2024 | $94.43M | +553.5% |
| 2023 | $14.45M | -59.3% |
| 2022 | $35.50M | -28.5% |
| 2021 | $49.64M | +16976.1% |
| 2020 | $290.7K | — |